We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05324813
Recruitment Status : Recruiting
First Posted : April 12, 2022
Last Update Posted : April 12, 2022
Sponsor:
Collaborator:
Dartmouth College
Information provided by (Responsible Party):
Michael Sofis, Advocates for Human Potential

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The overarching goal of this online study is to compare the efficacy of six (weekly) sessions of Domain-Specific Episodic Future Thinking (DS-EFT) relative an active control condition on improving the ability to value future rewards and reducing cannabis use (grams and days of use), tobacco use, and alcohol use among.

Condition or disease Intervention/treatment Phase
Marijuana Use Marijuana Dependence Tobacco Use Alcohol Use, Unspecified Behavioral: Domain-Specific Episodic Future Thinking Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use
Estimated Study Start Date : April 2022
Estimated Primary Completion Date : July 2022
Estimated Study Completion Date : July 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Marijuana

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Domain-Specific Episodic Future Thinking Behavioral: Domain-Specific Episodic Future Thinking
Individualized intervention that provides systematic prompts to enable creation and envisioning of positive future events across multiple life domains.
Active Comparator: Episodic Recent Thinking Control Condition Behavioral: Domain-Specific Episodic Future Thinking
Individualized intervention that provides systematic prompts to enable creation and envisioning of positive future events across multiple life domains.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Number of cannabis use grams [ Time Frame: 1-week follow-up ]
  2. Number of cannabis use days [ Time Frame: 1-week follow-up ]

Secondary Outcome Measures :
  1. Number of tobacco use days [ Time Frame: 1-week follow-up ]
  2. Number of alcohol use days [ Time Frame: 1-week follow-up ]
  3. Number of tobacco use times [ Time Frame: 1-week follow-up ]
  4. Number of alcoholic drinks [ Time Frame: 1-week follow-up ]
  5. Rate of delay discounting [ Time Frame: 1-week follow-up ]
    5-trial adjusting delay discounting task


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • at least 18 or older
  • reside in the U.S.
  • report wanting to reduce cannabis use (4 or higher on scale of 1-10 with higher scores indicating greater desire to reduce use)
  • report using cannabis at least 10 days in the last month
  • report using cannabis at least 100 days in their lifetime
  • Data quality checks passed

Exclusion Criteria:

-

Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05324813


Contacts
Layout table for location contacts
Contact: Michael J Sofis, PhD 14128678991 msofis@ahpnet.com

Locations
Layout table for location information
United States, Massachusetts
AHP Corporate Office Recruiting
Sudbury, Massachusetts, United States, 01776
Contact: Michael Sofis    412-867-8991    sofismichael2@gmail.com   
Principal Investigator: Michael J. Sofis, PhD         
Sponsors and Collaborators
Michael Sofis
Dartmouth College
Investigators
Layout table for investigator information
Principal Investigator: Michael J Sofis, PhD AHP
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Michael Sofis, Senior Scientist, Advocates for Human Potential
ClinicalTrials.gov Identifier: NCT05324813    
Other Study ID Numbers: 7420
First Posted: April 12, 2022    Key Record Dates
Last Update Posted: April 12, 2022
Last Verified: April 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Supporting Materials: Study Protocol

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Marijuana Abuse
Marijuana Use
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders